Literature DB >> 23270087

The effects of opt-out legislation on data collection and surveillance of birth defects by the New Hampshire Birth Conditions Program, New Hampshire, United States, 2007-2009.

Simerpal Gill1, Stephanie Miller, Cheryl Broussard, Jennita Reefhuis.   

Abstract

BACKGROUND: The New Hampshire Birth Conditions Program (NHBCP) is a population-based, active case ascertainment surveillance system that monitors the occurrence of 45 birth defects across the state. A 2008 law requires a new opt-out procedure whereby legal guardians can choose whether or not to have identifiable information retained in the NHBCP database. The purpose of this study was to determine the effects of implementing this opt-out legislation on data collection and surveillance of birth defects by the NHBCP.
METHODS: Using surveillance data collected following implementation of the opt out legislation for the period January 1, 2007, through December 31, 2009, 2 opt-out groups were created: the identifiable information retained (IIR) group, consisting of families who did not choose to opt out, and the de-identified information retained group (DIIR), consisting of those who either chose to opt out or were treated as opt-out birth defect cases because their opt-out package was undeliverable. Descriptive statistics were calculated for each group, and chi-square or Fisher's exact tests were used to compare the proportion of select sociodemographic and medical characteristics between the 2 opt-out groups.
RESULTS: Of 776 infants, 120 (15.5%) fell into the DIIR group. Differences were observed by race/ethnicity (among non-Hispanic whites, 15% were in the DIIR group and among Hispanics, 33% were in the DIIR group; p=0.01) and by maternal age (among women 30-34 years of age, 11% were in the DIIR group, and among those 25 years of age or younger, 22% were in the DIIR group; p=0.05). Birth outcomes, payer source, county of residence, and common birth defect diagnoses did not differ between the opt-out groups.
CONCLUSION: This study demonstrated that there were significant differences in race/ethnicity and maternal age between parents who had de-identified information included in the NHBCP compared with those who did not choose to opt out. Although the surveillance of birth defects is not affected, the opportunities for certain types of research will be limited.

Entities:  

Mesh:

Year:  2012        PMID: 23270087      PMCID: PMC4532307     

Source DB:  PubMed          Journal:  J Registry Manag        ISSN: 1945-6131


  8 in total

1.  Public health. Ethics and the conduct of public health surveillance.

Authors:  Amy L Fairchild; Ronald Bayer
Journal:  Science       Date:  2004-01-30       Impact factor: 47.728

2.  The limits of privacy: surveillance and the control of disease.

Authors:  Ronald Bayer; Amy Fairchild
Journal:  Health Care Anal       Date:  2002

3.  Trends in the postfortification prevalence of spina bifida and anencephaly in the United States.

Authors:  Sheree L Boulet; Quanhe Yang; Cara Mai; Russell S Kirby; Julianne S Collins; James M Robbins; Robert Meyer; Mark A Canfield; Joe Mulinare
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2008-07

4.  Malformations due to presumed spontaneous mutations in newborn infants.

Authors:  K Nelson; L B Holmes
Journal:  N Engl J Med       Date:  1989-01-05       Impact factor: 91.245

5.  Characteristics influencing informed consent on a congenital malformations registry.

Authors:  C Law; M O Robertson; S R Panny; L M Wulff
Journal:  Am J Public Health       Date:  1988-05       Impact factor: 9.308

6.  HIPAA privacy rule and public health. Guidance from CDC and the U.S. Department of Health and Human Services.

Authors: 
Journal:  MMWR Suppl       Date:  2003-05-02

7.  Collection, use, and protection of population-based birth defects surveillance data in the united states.

Authors:  Cara T Mai; David J Law; Craig A Mason; Bradley D McDowell; Robert E Meyer; Debra Musa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2007-12

8.  Update on overall prevalence of major birth defects--Atlanta, Georgia, 1978-2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-01-11       Impact factor: 17.586

  8 in total
  1 in total

1.  Real-world data in the United Kingdom: opportunities and challenges.

Authors:  Laura McDonald; Dimitra Lambrelli; Radek Wasiak; Sreeram V Ramagopalan
Journal:  BMC Med       Date:  2016-06-24       Impact factor: 8.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.